Actively Recruiting

Phase Not Applicable
Age: 18Years - 55Years
All Genders
NCT06686680

Treatment of Post Traumatic Knee Osteoarthritis With Extracorporeal Shockwave Therapy

Led by Spaulding Rehabilitation Hospital · Updated on 2025-12-04

70

Participants Needed

1

Research Sites

74 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is recruiting current or former athletes who had ACL reconstruction surgery over a year ago and have been diagnosed with knee osteoarthritis (OA). We are doing the research to investigate the effects of extracorporeal shockwave therapy (ESWT) on pain, function, biomechanics, knee range of motion and strength, inflammation, and joint structure and integrity of the knee.

CONDITIONS

Official Title

Treatment of Post Traumatic Knee Osteoarthritis With Extracorporeal Shockwave Therapy

Who Can Participate

Age: 18Years - 55Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Previous ACL reconstruction using an autograft or allograft in the knee with post-traumatic osteoarthritis
  • At least one year has passed since ACL reconstruction surgery
  • Aged between 18 and 55 years
  • No mechanical symptoms or contraindications that would limit ability to complete the study
  • Knee Injury and Osteoarthritis Outcome Score (KOOS) score of 85 or lower in at least 2 of 4 domains: pain, symptoms, activities of daily living, or quality of life
  • Primary pain is from the knee
  • Diagnosis of post-traumatic osteoarthritis confirmed clinically and with radiographic evidence prior to enrollment
Not Eligible

You will not qualify if you...

  • Received injections to the knee joint within the past 3 months
  • Pregnant women or those planning to become pregnant
  • Neuropathy affecting pain sensation
  • Known cardiac disease that could be affected by shockwave therapy
  • Chronic rheumatological conditions, immunodeficiency, severe asthma, connective tissue disorders, or other medical conditions impacting inflammation or requiring chronic immune modulatory medications (mild asthma with inhaler use is allowed)
  • Active use of oral steroids or anti-inflammatories at enrollment
  • Bilateral ACL injury or reconstruction or ACL revision surgery
  • Active malignancy or less than five years in remission
  • Previous ESWT treatment with study devices for knee osteoarthritis
  • Presence of pacemaker, bone screws, or metal implants that prevent MRI or ESWT participation
  • Non-English speaking individuals

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Spaulding Cambridge Hospital

Cambridge, Massachusetts, United States, 02138

Actively Recruiting

Loading map...

Research Team

A

Adam S Tenforde, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here